HPV16 ANTIBODIES AS DIAGNOSTIC AND PROGNOSTIC BIOMARKERS IN PRE-INVASIVE AND INVASIVE DISEASE

摘要

Methods and systems for detection of HPV mediated cervical or oropharyneal cancer are provided. The methods include contacting a fluid sample from a patient with multiple antibodies to HPV16 early gene proteins and comparing patterns of HPV16 antibody bound to said early gene proteins with a control associated with cervical or oropharyneal cancer (Fig. 1).